{
    "nctId": "NCT02996916",
    "officialTitle": "Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue",
    "inclusionCriteria": "* Written informed consent obtained\n* Male and female subjects aged 20 years or older at informed consent\n* Essential hypertension who had never received angiotensin II receptor antagonists and calcium channel blockers\n* Must have minimum age of 20 Years",
    "exclusionCriteria": "* Secondary hypertension or malignant hypertension\n* Diabetes mellitus\n* History or evidence of a stroke\n* Hepatic or hematologic abnormality\n* Mild Cognitive Impairment or Dementia\n* Serum potassium level \u2265 5.5 mEq/L\n* Serum creatinine level \u2265 3.0 mg/dL\n* Acute or chronic disease\n* Allergy to any drugs\n* Pregnancy"
}